English version
Instituts/ Institut d'imagerie biomédicale (I²BM)/ Services/ MIRCen (MIRCen)/ Publications

Publications  - 2006

2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004
  1. Arango M, Holbert S, Zala D, Brouillet E, Pearson J, Regulier E, Thakur AK, Aebischer P, Wetzel R, Deglon N, Neri C (2006) CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J Neurosci 26:4649-4659.
  2. Bachoud-Levi AC, Gaura V, Brugieres P, Lefaucheur JP, Boisse MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M (2006) Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5:303-309.
  3. Baudic S, Barba GD, Thibaudet MC, Smagghe A, Remy P, Traykov L (2006) Executive function deficits in early Alzheimer's disease and their relations with episodic memory. Arch Clin Neuropsychol 21:15-21.
  4. Benaderette S, Fregonara PZ, Apartis E, Nguyen C, Trocello JM, Remy P, Devaux JY, Askienazy S, Vidailhet M (2006) Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord 21:310-317.
  5. Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Deglon N, Brouillet E (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 17:1652-1663.
  6. Borrell-Pages M, Canals JM, Cordelieres FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Neri C, Alberch J, Brouillet E, Saudou F, Humbert S (2006) Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest 116:1410-1424.
  7. Delatour B, Guegan M, Volk A, Dhenain M (2006) In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol Aging 27:835-847.
  8. Dhenain M, Delatour B, Walczak C, Volk A (2006) Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease. Magn Reson Med 55:687-693.
  9. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P (2006) Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study. Neuroimage 32:1562-1575.
  10. Duteil S, Wary C, Raynaud JS, Lebon V, Lesage D, Leroy-Willig A, Carlier PG. Influence of vascular filling and perfusion on BOLD contrast during reactive hyperemia in human skeletal muscle. Magn Reson Med 55:450-4.
  11. El Tannir El Tayara N, Delatour B, Le Cudennec C, Guegan M, Volk A, Dhenain M (2006) Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 22:199-208.
  12. Escartin C, Brouillet E, Gubellini P, Trioulier Y, Jacquard C, Smadja C, Knott GW, Kerkerian-Le Goff L, Deglon N, Hantraye P, Bonvento G (2006a) Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J Neurosci 26:5978-5989.
  13. Escartin C, Valette J, Lebon V, Bonvento G (2006b) Neuron-astrocyte interactions in the regulation of brain energy metabolism: a focus on NMR spectroscopy. J Neurochem 99:393-401.
  14. Gsell W, Burke M, Wiedermann D, Bonvento G, Silva AC, Dauphin F, Buhrle C, Hoehn M, Schwindt W (2006) Differential effects of NMDA and AMPA glutamate receptors on functional magnetic resonance imaging signals and evoked neuronal activity during forepaw stimulation of the rat. J Neurosci 26:8409-8416.
  15. Jacquard C, Trioulier Y, Cosker F, Escartin C, Bizat N, Hantraye P, Cancela JM, Bonvento G, Brouillet E (2006) Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation. Faseb J 20:1021-1023.
  16. Kappeler C, Dhenain M, Phan Dinh Tuy F, Saillour Y, Marty S, Fallet-Bianco C, Souville I, Souil E, Pinard J-M, Meyer G, Encha-Razavi F, Volk A, Beldjord C, Chelly J, Francis F (2007). MRI and histological studies of corpus callosal and hippocampal abnormalities linked to doublecortin deficiency. Journal of Comparative Neurology 500:239–254.
  17. Krystkowiak P, Gaura V, Dessaint J-P, Remy P, Peschanski M, Bachoud-Lévi A-C. (2006) Reversible immune response to fœtal grafts in the brain of a patient with Huntington’s disease. Public Library of Science, sous presse.
  18. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes 55:929-34.
  19. Pardo R, Colin E, Regulier E, Aebischer P, Deglon N, Humbert S, Saudou F (2006) Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci 26:1635-1645.
  20. Quintana C, Wu TD, Delatour B, Dhenain M, Guerquin-Kern J-L, Croisy A (2006) Morphological and chemical studies of pathological human and mice brain at the sub cellular level: correlation between light, electron and nanoSIMS microscopies. Microscopy Research and Technique, in press.
  21. Ridet JL, Bensadoun JC, Deglon N, Aebischer P, Zurn AD (2006) Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease. Neurobiol Dis 21:29-34.
  22. Rosso C, Remy P, Creange A, Brugieres P, Cesaro P, Hosseini H (2006) Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. AJNR Am J Neuroradiol 27:1006-1008.
  23. Sedel F, Ribeiro M.J., Remy P, Blau N, Saudubray J.M., Agid Y. (2006) Dihydropteridine reductase deficiency: levodopa long term effectiveness without dyskinesia. Neurology, sous presse.
  24. Thominiaux C, Dolle F, James ML, Bramoulle Y, Boutin H, Besret L, Gregoire MC, Valette H, Bottlaender M, Tavitian B, Hantraye P, Selleri S, Kassiou M (2006) Improved synthesis of the peripheral benzodiazepine receptor ligand [11C]DPA-713 using [11C]methyl triflate. Appl Radiat Isot 64:570-573.
  25. Valette J, Guillermier M, Boumezbeur F, Poupon C, Amadon A, Hantraye P, Lebon V (2006) B(0) homogeneity throughout the monkey brain is strongly improved in the sphinx position as compared to the supine position. J Magn Reson Imaging 23:408-412.
  26. Valette J, Guillermier M, Besret L, Hantraye P, Bloch G, Lebon V. Isoflurane strongly affects the diffusion of intracellular metabolites, as shown by 1H-NMR spectroscopy of the monkey brain. J Cereb Blood Flow Metab, sous presse.
2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004